A Proof of Concept Study of Inhaled Nitric Oxide for Adults With Pulmonary Non-Tuberculous Mycobacterial Infection

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 28, 2019

Primary Completion Date

March 26, 2020

Study Completion Date

March 26, 2020

Conditions
Nontuberculous Mycobacterium Infection
Interventions
DRUG

gNO

"This is a proof-of-concept study in which all subjects will be treated with gNO (i.e. no control) to see if there can be a microbiological effect by conversion to negative sputum cultures and how long that effect can be sustained following treatment.~Participants will be treated for 3 weeks (5 days per week), Monday through Friday, and followed monthly for 3 months.~The treatment period includes a physical exam, vital signs, blood tests, echocardiogram, spirometry test, sputum sample, questionnaires, and the inhalation gas treatment. During the inhalation gas treatment, participants will wear a face mask (similar to an oxygen mask) and will be given nitric oxide gas through the participants nose for three treatments with fifty minutes each time. They will then be followed up monthly during the Follow-up period with tests that include a physical exam and questionnaires."

Trial Locations (2)

29425

Medical University of South Carolina, Charleston

97239

Oregon Health and Science University, Portland

All Listed Sponsors
collaborator

Cystic Fibrosis Foundation

OTHER

collaborator

Oregon Health and Science University

OTHER

lead

Medical University of South Carolina

OTHER

NCT03748992 - A Proof of Concept Study of Inhaled Nitric Oxide for Adults With Pulmonary Non-Tuberculous Mycobacterial Infection | Biotech Hunter | Biotech Hunter